Related Experiment Videos
The DREAM-DRE interaction: key nucleotides and dominant negative mutants.
F Ledo1, W A Link, A M Carrión
1Departamento Biología Molecular y Celular, L115, Centro Nacional de Biotecnología, C.S.I.C., Campus Cantoblanco, 28049, Madrid, Spain.
Biochimica Et Biophysica Acta
|December 8, 2000
Summary
Calcium-binding protein DREAM represses gene expression by binding DNA. Mutations blocking calcium-induced release create dominant negative mutants, impacting gene regulation.
Area of Science:
- Molecular Biology
- Gene Regulation
- Protein-DNA Interactions
Background:
- Transcriptional repressor DREAM binds DNA at DRE sites to inhibit gene expression.
- DREAM is a calcium-binding protein, and its release from DNA is calcium-dependent.
- The DNA sequence GTCA is central to DRE sites, with flanking nucleotides affecting DREAM affinity.
Purpose of the Study:
- To investigate the role of calcium in DREAM-mediated gene repression.
- To identify mutations that disrupt calcium-dependent derepression.
- To characterize dominant negative mutants of DREAM.
Main Methods:
- Site-directed mutagenesis of EF-hand domains in DREAM.
- Analysis of DREAM binding to DRE sequences in vitro.
- Assessment of gene expression changes in response to DREAM mutants and calcium levels.
Main Results:
- Specific mutations within an EF-hand of DREAM abolish calcium-induced derepression.
- These mutations render DREAM a potent dominant negative inhibitor of endogenous DREAM.
- DREAM's interaction with DRE sites is crucial for its repressive function.
Conclusions:
- Calcium regulation of DREAM binding is critical for dynamic gene expression control.
- Engineered DREAM mutants can be used to study or disrupt endogenous DREAM function.
- Understanding DREAM's mechanism provides insights into calcium signaling and gene regulation.